Waiting Period After Stopping Flecainide Before Loading Amiodarone
No specific waiting period is required after stopping flecainide before initiating amiodarone loading, as these medications can be used sequentially or even in combination without a mandatory washout period. 1
Key Evidence and Rationale
Drug Interaction Profile
- The 2015 ACC/AHA/HRS guidelines explicitly list flecainide and amiodarone as having known drug interactions, noting that amiodarone increases flecainide levels through P-glycoprotein and CYP450 inhibition, but this does not contraindicate sequential use. 1
- When used together, digoxin and flecainide doses should be monitored due to amiodarone's effects, but no washout period is specified for transitioning between these agents. 1
Clinical Practice Evidence
- Combination therapy with amiodarone and flecainide has been successfully used in clinical practice, with one case report documenting 15 years of safe concurrent use for refractory atrial fibrillation without requiring a washout period when initiating the combination. 2
- Multiple guidelines discuss sequential use of class IC agents (flecainide) followed by class III agents (amiodarone) without mentioning mandatory waiting periods. 1
Practical Approach to Transition
When transitioning from flecainide to amiodarone:
Stop flecainide and begin amiodarone loading immediately if clinically indicated, particularly in patients with structural heart disease where flecainide is contraindicated but amiodarone is preferred. 1, 3
Monitor the ECG closely during the transition, specifically:
Consider reducing the amiodarone loading dose if there is concern about additive effects, though standard loading regimens (600 mg daily for 4 weeks or 1 g daily for 1 week) are generally safe even without a washout period. 1
Important Caveats
Avoid this transition in specific circumstances:
- Atrial flutter with 1:1 AV conduction is a concern with flecainide; ensure adequate rate control before stopping flecainide if flutter is present. 1
- Severe bradycardia or high-degree AV block from flecainide should resolve (typically within 24-48 hours) before loading amiodarone, as both drugs can cause conduction abnormalities. 1
- Structural heart disease is actually an indication to transition quickly from flecainide to amiodarone, as flecainide is contraindicated but amiodarone is relatively safe in this population. 1, 3
Monitoring During Transition
Essential monitoring parameters:
- Baseline ECG before starting amiodarone to document resolution of flecainide's effects on QRS duration 1
- Electrolytes (potassium, magnesium) should be normal before amiodarone loading 1
- Heart rate monitoring for excessive bradycardia, particularly in the first week 1
- If outpatient transition, weekly pulse checks or event recorder monitoring 1
The evidence supports immediate transition without a mandatory washout period, with appropriate clinical monitoring for additive conduction effects during the first 24-48 hours. 1